On June 12, 2025, Halper Sadeh LLC, an investor rights law firm, disclosed an ongoing investigation into select companies. Inozyme Pharma, Inc. (NASDAQ: INZY) is one of the companies under scrutiny for potential infringements of federal securities laws or breaches of fiduciary responsibilities towards shareholders. The investigation aims to address issues impacting shareholder interests within these companies.